Qiagen (QGEN) Upgraded to Buy by Deutsche Bank After 30% Decline [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
Hold, maintaining a $54 price target on the company's shares. The firm stated that Qiagen's stock had declined over 30% since late January's M&A stories and accompanying downgrade, essentially pricing out any buyout premium. According to the firm, the company's 2026 outlook is back-end heavy, which is common among Diagnostics and Life Sciences competitors and is due in part to mechanical impacts reasonably reflected in current consensus estimates. Qiagen N.V. (NYSE:QGEN) also outlined its strategy at the Barclays 28th Annual Global Healthcare Conference on March 10, emphasizing sustainable development objectives in the midst of a CEO transition. Despite macroeconomic challenges and the temporary impact of discontinued products such as NeuMoDx, the company reiterated its 5% full-year growth estimate. Growth is likely to improve in the second half, boosted by the introduction of new sample-preparation products that could add up to 200 basis points to results. Qiagen N.V. (NYSE:Q
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Qiagen Announces Form 20-F Annual Report Filing for 2025 Results [Yahoo! Finance]Yahoo! Finance
- Qiagen Announces Form 20-F Annual Report Filing for 2025 ResultsBusiness Wire
- QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention [Yahoo! Finance]Yahoo! Finance
- QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB PreventionBusiness Wire
- Qiagen (QGEN) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
QGEN
Earnings
- 2/4/26 - Beat
QGEN
Sec Filings
- 3/20/26 - Form 20-F
- 3/20/26 - Form IRANNOTICE
- 2/10/26 - Form SCHEDULE
- QGEN's page on the SEC website